Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05009992
Title Combination Therapy for the Treatment of Diffuse Midline Gliomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | NZL | NLD | ISR | CHE | AUS


No variant requirements are available.